powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1679957187
Ferdinandos Skoulidis
M.D.
PRACTICE
MDACC
See all providers at this practice →
Medical Oncology
Houston,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
70.8
Cost
67.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
110
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
4
Brand share
57.3%
Top prescribed drugs
Osimertinib Mesylate
63 claims
Erlotinib Hcl
16 claims
Ondansetron Hcl
16 claims
Dexamethasone
15 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$37K
Payment records
37
By payment type
Consulting Fee
$29K
Travel and Lodging
$5K
Honoraria
$1K
Food and Beverage
$1K
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
126
Unique beneficiaries
—
Total services
266
Distinct HCPCS
3
Medicare payment
$22K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 393 Medical Oncology providers in TX — bottom quintile (cohort median 4,999).
